Bioanalytical Testing Services Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Bioanalytical Testing Services Market 

5.1. COVID-19 Landscape: Bioanalytical Testing Services Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Bioanalytical Testing Services Market, By Test Type

8.1. Bioanalytical Testing Services Market, by Test Type, 2024-2034

8.1.1. Pharmacokinetic

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Pharmacodynamics

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Bioavailability

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Bioequivalence

8.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Bioanalytical Testing Services Market, By Molecules

9.1. Bioanalytical Testing Services Market, by Molecules, 2024-2034

9.1.1. Small Molecules

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Large Molecules

9.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Bioanalytical Testing Services Market, By Application 

10.1. Bioanalytical Testing Services Market, by Application, 2024-2034

10.1.1. Cardiology

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Gastroenterology

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Neurology

10.1.3.1. Market Revenue and Forecast (2021-2034)

10.1.4. Oncology

10.1.4.1. Market Revenue and Forecast (2021-2034)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Bioanalytical Testing Services Market, By End User 

11.1. Bioanalytical Testing Services Market, by End User, 2024-2034

11.1.1. Pharmaceutical and Biopharmaceutical Companies

11.1.1.1. Market Revenue and Forecast (2021-2034)

11.1.2. Contract Development and Manufacturing Organizations

11.1.2.1. Market Revenue and Forecast (2021-2034)

11.1.3. Contract Research Organizations

11.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 12. Global Bioanalytical Testing Services Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Test Type (2021-2034)

12.1.2. Market Revenue and Forecast, by Molecules (2021-2034)

12.1.3. Market Revenue and Forecast, by Application (2021-2034)

12.1.4. Market Revenue and Forecast, by End User (2021-2034)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Test Type (2021-2034)

12.1.5.2. Market Revenue and Forecast, by Molecules (2021-2034)

12.1.5.3. Market Revenue and Forecast, by Application (2021-2034)

12.1.5.4. Market Revenue and Forecast, by End User (2021-2034)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Test Type (2021-2034)

12.1.6.2. Market Revenue and Forecast, by Molecules (2021-2034)

12.1.6.3. Market Revenue and Forecast, by Application (2021-2034)

12.1.6.4. Market Revenue and Forecast, by End User (2021-2034)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Test Type (2021-2034)

12.2.2. Market Revenue and Forecast, by Molecules (2021-2034)

12.2.3. Market Revenue and Forecast, by Application (2021-2034)

12.2.4. Market Revenue and Forecast, by End User (2021-2034)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Test Type (2021-2034)

12.2.5.2. Market Revenue and Forecast, by Molecules (2021-2034)

12.2.5.3. Market Revenue and Forecast, by Application (2021-2034)

12.2.5.4. Market Revenue and Forecast, by End User (2021-2034)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Test Type (2021-2034)

12.2.6.2. Market Revenue and Forecast, by Molecules (2021-2034)

12.2.6.3. Market Revenue and Forecast, by Application (2021-2034)

12.2.6.4. Market Revenue and Forecast, by End User (2021-2034)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Test Type (2021-2034)

12.2.7.2. Market Revenue and Forecast, by Molecules (2021-2034)

12.2.7.3. Market Revenue and Forecast, by Application (2021-2034)

12.2.7.4. Market Revenue and Forecast, by End User (2021-2034)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Test Type (2021-2034)

12.2.8.2. Market Revenue and Forecast, by Molecules (2021-2034)

12.2.8.3. Market Revenue and Forecast, by Application (2021-2034)

12.2.8.4. Market Revenue and Forecast, by End User (2021-2034)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Test Type (2021-2034)

12.3.2. Market Revenue and Forecast, by Molecules (2021-2034)

12.3.3. Market Revenue and Forecast, by Application (2021-2034)

12.3.4. Market Revenue and Forecast, by End User (2021-2034)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Test Type (2021-2034)

12.3.5.2. Market Revenue and Forecast, by Molecules (2021-2034)

12.3.5.3. Market Revenue and Forecast, by Application (2021-2034)

12.3.5.4. Market Revenue and Forecast, by End User (2021-2034)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Test Type (2021-2034)

12.3.6.2. Market Revenue and Forecast, by Molecules (2021-2034)

12.3.6.3. Market Revenue and Forecast, by Application (2021-2034)

12.3.6.4. Market Revenue and Forecast, by End User (2021-2034)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Test Type (2021-2034)

12.3.7.2. Market Revenue and Forecast, by Molecules (2021-2034)

12.3.7.3. Market Revenue and Forecast, by Application (2021-2034)

12.3.7.4. Market Revenue and Forecast, by End User (2021-2034)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Test Type (2021-2034)

12.3.8.2. Market Revenue and Forecast, by Molecules (2021-2034)

12.3.8.3. Market Revenue and Forecast, by Application (2021-2034)

12.3.8.4. Market Revenue and Forecast, by End User (2021-2034)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Test Type (2021-2034)

12.4.2. Market Revenue and Forecast, by Molecules (2021-2034)

12.4.3. Market Revenue and Forecast, by Application (2021-2034)

12.4.4. Market Revenue and Forecast, by End User (2021-2034)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Test Type (2021-2034)

12.4.5.2. Market Revenue and Forecast, by Molecules (2021-2034)

12.4.5.3. Market Revenue and Forecast, by Application (2021-2034)

12.4.5.4. Market Revenue and Forecast, by End User (2021-2034)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Test Type (2021-2034)

12.4.6.2. Market Revenue and Forecast, by Molecules (2021-2034)

12.4.6.3. Market Revenue and Forecast, by Application (2021-2034)

12.4.6.4. Market Revenue and Forecast, by End User (2021-2034)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Test Type (2021-2034)

12.4.7.2. Market Revenue and Forecast, by Molecules (2021-2034)

12.4.7.3. Market Revenue and Forecast, by Application (2021-2034)

12.4.7.4. Market Revenue and Forecast, by End User (2021-2034)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Test Type (2021-2034)

12.4.8.2. Market Revenue and Forecast, by Molecules (2021-2034)

12.4.8.3. Market Revenue and Forecast, by Application (2021-2034)

12.4.8.4. Market Revenue and Forecast, by End User (2021-2034)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Test Type (2021-2034)

12.5.2. Market Revenue and Forecast, by Molecules (2021-2034)

12.5.3. Market Revenue and Forecast, by Application (2021-2034)

12.5.4. Market Revenue and Forecast, by End User (2021-2034)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Test Type (2021-2034)

12.5.5.2. Market Revenue and Forecast, by Molecules (2021-2034)

12.5.5.3. Market Revenue and Forecast, by Application (2021-2034)

12.5.5.4. Market Revenue and Forecast, by End User (2021-2034)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Test Type (2021-2034)

12.5.6.2. Market Revenue and Forecast, by Molecules (2021-2034)

12.5.6.3. Market Revenue and Forecast, by Application (2021-2034)

12.5.6.4. Market Revenue and Forecast, by End User (2021-2034)

Chapter 13. Company Profiles

13.1. PPD, Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. ICON Plc

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Charles River Laboratories International

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Covance, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. IQVIA

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Syneos Health

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. SGS SA

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Toxikon

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Intertek Group Plc

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Pace Analytical Services LLC

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms